Toripalimab in Combination With R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma
Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This study will research untreated elderly diffuse large B cell lymphoma patients respond and
safty to toripalimab combined with R-CHOP chemotherapy regimen (rituximab, cyclophosphamide,
doxorubicin, vincristine, prednisone) therapy.